Top Story

Diabetes drug adherence drops with cancer diagnoses

January 29, 2015

Adherence to glucose-lowering medications among patients with diabetes appears to diminish after they are diagnosed with cancer, according to research published in Diabetologia.

“This study revealed that diabetes patients became less adherent to their prescribed diabetes drugs following a cancer diagnosis,” Marjolein M. J. Zanders, MD, of the department of research at Netherlands Comprehensive Cancer Organization in Eindhoven, the Netherlands, told Endocrine Today.

In the Journals

Patients with OA more likely to self-report lower weight, BMI

January 29, 2015
In Norway, patients with osteoarthritis were more likely to underreport their weight and BMI, according to recently published findings.A group of 600 patients, 449 of…
In the Journals

Insulin resistance-related lipoproteins linked to diabetes risk

January 28, 2015
Lipoprotein-based insulin resistance, very low density lipoprotein concentration and size, triglycerides and their ratio with HDL cholesterol were associated with…
In the Journals

Weight loss linked to improved sleep, mood

January 28, 2015
Losing 5% or more from initial body weight is associated with short-term improvements in sleep quality and duration, and short- and long-term improvements in mood…
Amber Cooper In the Journals

EDC exposure may lead to early menopause

January 28, 2015
Exposure to endocrine-disrupting chemicals could lead to early menopause, which could not only alter quality of life for women, but affect fertility, human reproduction…
More News Headlines »
CME
Experts Take: Dialogue on HTG

Experts’ Take: Dialogue on Hypertriglyceridemia

This activity is supported by an independent educational grant from Amarin Pharma Inc.

Lead by genetic studies, recent data describe a causal role of triglycerides (TG) in the formation of atherosclerosis…
More »
Meeting News Coverage Video
Hatipoglu th

Autologous islet cell transplantation effective for chronic pancreatitis

December 3, 2014
In this video exclusive, Betul Hatipoglu, MD, clinical associate professor of medicine of the Endocrinology &…
More »
CME
Screening and Treatment of Diabetes-Associated Eye Disease

Screening and Treatment of Diabetes-Associated Eye Disease: Out of Sight, Out of Mind?

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Diabetic retinopathy is a major cause of blindness among adults aged 40 years and older. Optimal outcomes necessitates…
More »
Current Issues
View the Current Issues
morganatic-roan